EUR/USD 1.14153
-0.125%
Gold 4108.33
-0.370%
Oil 71.472
-0.264%
USD/JPY 161.729
-0.397%
GBP/USD 1.33978
-0.077%
GBP/JPY 216.686
-0.473%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
July 12th - On Saturday evening local time, despite Trumps refusal to sign it, the landmark bipartisan housing bill automatically went into effect, prompting celebrations from several members of the House and Senate. The Path to a Better Home Act aims to expand housing supply, increase homeownership rates, alleviate the housing shortage crisis in the United States, and improve housing affordability through measures such as relaxing regulations on residential construction and restricting Wall Street firms from acquiring ordinary homes.The China Earthquake Networks Center officially measured a 3.8-magnitude earthquake in Arong Banner, Hulunbuir City, Inner Mongolia, at 05:09 on July 12, with a focal depth of 10 kilometers.According to an Elabe poll for BFM, Marine Le Pen, the far-right National Rally candidate, is expected to receive 34% to 35.5% of the vote if the first round of voting is held this Sunday.The National Press Club of America has called on the U.S. Department of Justice to immediately withdraw the subpoena for the New York Times reporter.On July 12th, Meta announced that earlier this week, users could generate images in Meta AI by mentioning public Instagram accounts they wanted to reference. This feature, which allowed referencing public content by default, drew criticism from organizations such as the Screen Actors Guild, who argued it could infringe on portrait rights and pose criminal risks. Meta stated that its initial intention was to provide a practical creative tool and allow users to control whether their public content was allowed to be referenced in this way, but after receiving user feedback that the feature failed to achieve its intended effect, it has been removed.

Biogen finalizes $900 million drug kickback settlement

Norah Atkinson

Sep 27, 2022 14:30

6.png


The U.S. Department of Justice announced on Monday that Biogen Inc. has struck a $900 million deal to resolve a whistleblower case that accused the biotech company of paying kickbacks to doctors who prescribed multiple sclerosis drugs.


The settlement closes a lengthy whistleblower action filed in Boston federal court by a former government employee. Biogen (NASDAQ:BIIB) disclosed in July that a potential settlement had been reached, pending government clearance.


According to his attorney, Thomas Greene, former employee Michael Bawduniak will receive $266,4 million for pursuing the action. Greene noted that this sum surpasses all previous records for whistleblower payouts in the United States.


Cambridge is located in Massachusetts As part of the agreement, Biogen did not acknowledge guilt. Biogen indicated in a statement that the corporation "believes that its goals and conduct have always been legitimate and appropriate."


From 2009 to 2014, Biogen was suspected of paying doctors millions of dollars in kickbacks to prescribe Avonex, Tysabri, and Tecfidera for multiple sclerosis. According to the lawsuit, the payments included "false" consulting deals and speaker programs, as well as lavish dinners and entertainment.


Allegedly, the scam resulted in the filing of false claims for payment to the federal healthcare programs Medicare and Medicaid.


Bawduniak filed the lawsuit in 2012 under the False Claims Act, which empowers whistleblowers to sue companies on behalf of the government to recover fraudulently obtained taxpayer monies.


The Justice Department may intervene in such situations and alleviate them itself following an investigation; however, it declined to do so in Bawduniak's case in 2015, allowing him to pursue the matter on his own.


His attorney, Greene, has described the settlement as the greatest recovery in over 150 years of False Claims Act cases won by a whistleblower without government intervention.

Suggestion